Literature DB >> 19651904

Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance.

Yuki Furuse1, Akira Suzuki, Hitoshi Oshitani.   

Abstract

Influenza A virus infects many species, and amantadine is used as an antiviral agent. Recently, a substantial increase in amantadine-resistant strains has been reported, most of which have a substitution at amino acid position 31 in the M2 gene. Understanding the mechanism responsible for the emergence and spread of antiviral resistance is important for developing a treatment protocol for seasonal influenza and for deciding on a policy for antiviral stockpiling for pandemic influenza. The present study was conducted to identify the existence of drug pressure on the emergence and spread of amantadine-resistant influenza A viruses. We analyzed data on more than 5,000 virus sequences and constructed a phylogenetic tree to calculate selective pressures on sites in the M2 gene associated with amantadine resistance (positions 26, 27, 30, and 31) among different hosts. The phylogenetic tree revealed that the emergence and spread of the drug-resistant M gene in different hosts and subtypes were independent and not through reassortment. For human influenza virus, positive selection was detected only at position 27. Selective pressures on the sites were not always higher for human influenza virus than for viruses of other hosts. Additionally, selective pressure on position 31 did not increase after the introduction of amantadine. Although there is a possibility of drug pressure on human influenza virus, we could not find positive pressure on position 31. Because the recent rapid increase in drug-resistant virus is associated with the substitution at position 31, the resistance may not be related to drug use.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651904      PMCID: PMC2764202          DOI: 10.1128/AAC.00650-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.

Authors:  Chung-Lam Cheung; Jane M Rayner; Gavin J D Smith; Pui Wang; T S P Naipospos; Jinxia Zhang; Kwok-Yung Yuen; Robert G Webster; J S Malik Peiris; Yi Guan; Honglin Chen
Journal:  J Infect Dis       Date:  2006-05-09       Impact factor: 5.226

2.  The influenza virus resource at the National Center for Biotechnology Information.

Authors:  Yiming Bao; Pavel Bolotov; Dmitry Dernovoy; Boris Kiryutin; Leonid Zaslavsky; Tatiana Tatusova; Jim Ostell; David Lipman
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

3.  Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season.

Authors:  Yuki Furuse; Akira Suzuki; Taro Kamigaki; Midori Shimizu; Naoko Fuji; Hitoshi Oshitani
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

Review 4.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

5.  Natural selection on the influenza virus genome.

Authors:  Yoshiyuki Suzuki
Journal:  Mol Biol Evol       Date:  2006-07-03       Impact factor: 16.240

6.  Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins.

Authors:  R A Lamb; C J Lai; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

7.  Coordinated evolution of the hepatitis C virus.

Authors:  D S Campo; Z Dimitrova; R J Mitchell; J Lara; Y Khudyakov
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-09       Impact factor: 11.205

Review 8.  The potential impact of neuraminidase inhibitor resistant influenza.

Authors:  Angie Lackenby; Catherine I Thompson; Jane Democratis
Journal:  Curr Opin Infect Dis       Date:  2008-12       Impact factor: 4.915

9.  Amantadine-resistance as a genetic marker for influenza viruses.

Authors:  G Appleyard
Journal:  J Gen Virol       Date:  1977-08       Impact factor: 3.891

10.  The molecular basis of the specific anti-influenza action of amantadine.

Authors:  A J Hay; A J Wolstenholme; J J Skehel; M H Smith
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

View more
  43 in total

1.  An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.

Authors:  Yanmei Hu; Rami Musharrafieh; Chunlong Ma; Jiantao Zhang; Donald F Smee; William F DeGrado; Jun Wang
Journal:  Antiviral Res       Date:  2017-01-10       Impact factor: 5.970

2.  Exploring organosilane amines as potent inhibitors and structural probes of influenza a virus M2 proton channel.

Authors:  Jun Wang; Chunlong Ma; Yibing Wu; Robert A Lamb; Lawrence H Pinto; William F DeGrado
Journal:  J Am Chem Soc       Date:  2011-08-12       Impact factor: 15.419

3.  Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.

Authors:  Xin Zhao; Runfeng Li; Yang Zhou; Mengjie Xiao; Chunlong Ma; Zhongjin Yang; Shaogao Zeng; Qiuling Du; Chunguang Yang; Haiming Jiang; Yanmei Hu; Kefeng Wang; Chris Ka Pun Mok; Ping Sun; Jianghong Dong; Wei Cui; Jun Wang; Yaoquan Tu; Zifeng Yang; Wenhui Hu
Journal:  J Med Chem       Date:  2018-06-11       Impact factor: 7.446

4.  Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31N Inhibitors Using the Suzuki-Miyaura Cross-Coupling Reaction.

Authors:  Fang Li; Yanmei Hu; Yuanxiang Wang; Chunlong Ma; Jun Wang
Journal:  J Med Chem       Date:  2017-02-09       Impact factor: 7.446

Review 5.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

6.  X-ray Crystal Structure of the Influenza A M2 Proton Channel S31N Mutant in Two Conformational States: An Open and Shut Case.

Authors:  Jessica L Thomaston; Yibing Wu; Nicholas Polizzi; Lijun Liu; Jun Wang; William F DeGrado
Journal:  J Am Chem Soc       Date:  2019-07-11       Impact factor: 15.419

7.  Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.

Authors:  Victoria Balannik; Jun Wang; Yuki Ohigashi; Xianghong Jing; Emma Magavern; Robert A Lamb; William F Degrado; Lawrence H Pinto
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

8.  Investigation of the Drug Resistance Mechanism of M2-S31N Channel Blockers through Biomolecular Simulations and Viral Passage Experiments.

Authors:  Rami Musharrafieh; Panagiotis Lagarias; Chunlong Ma; Raymond Hau; Alex Romano; George Lambrinidis; Antonios Kolocouris; Jun Wang
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-31

9.  3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.

Authors:  Matias Rey-Carrizo; Eva Torres; Chunlong Ma; Marta Barniol-Xicota; Jun Wang; Yibing Wu; Lieve Naesens; William F DeGrado; Robert A Lamb; Lawrence H Pinto; Santiago Vázquez
Journal:  J Med Chem       Date:  2013-11-15       Impact factor: 7.446

10.  Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.

Authors:  Fang Li; Chunlong Ma; Yanmei Hu; Yuanxiang Wang; Jun Wang
Journal:  ACS Infect Dis       Date:  2016-09-22       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.